FDA changes course over shortage of weight-loss drugs
Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Record Drug Bust in Mexico
The family eventually found that medication. Later, two others Abby needed were hard to find. The Brays, like thousands of ...
Tablets labeled as dietary supplements for joint pain and arthritis are being recalled after the FDA found three undeclared ...
Researchers from Loyola University Chicago are adding to the growing evidence suggesting that medications like Ozempic can ...
U.S. Sen. Amy Klobuchar joined Lanon Baccam in Des Moines Friday for a fundraiser and roundtable discussion focused on ...
An off-label clot-busting drug appears to work slightly better in treating stroke patients than an approved medication, a new ...
The Brighterside of News on MSN3h
New class of drugs target brain metabolism to treat Alzheimer’s patientsRecent research highlights the potential of targeting the brain’s metabolism to treat Alzheimer’s disease, a condition that ...
The report said that one of the handguns had a loaded high-capacity drum magazine and a full-automatic conversion kit, which ...
A Youngstown couple is facing charges after Mahoning County Prosecutors say they tried to have drugs snuck into the jail.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback